Age-dependent antibody response to Plasmodium falciparum merozoite surface protein 2 (MSP-2)

Parasite Immunology

Volumn 33, Issue 3, 2011, Pages 145-157

  Khosravi, A ^a   Hommel, M ^b   Sayemiri, K ^a  

^a ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b INSTITUT PASTEUR   (France)

Author keywords

Age dependent; Immunity; Malaria; MSP 2; Plasmodium falciparum

Indexed keywords

HEMOGLOBIN; IMMUNOGLOBULIN G; MEROZOITE SURFACE PROTEIN 2;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDEMIC SPECIES; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFANT; KOLMOGOROV SMIRNOV TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA; MALE; NEWBORN; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMORPHIC LOCUS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DOMAIN; SCHIZONT; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMBIA; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; YOUNG ADULT;

PLASMODIUM FALCIPARUM;

EID: 79751471380     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2010.01260.x     Document Type: Article

References (41)

1. Ocampo M, Urquiza M, Guzman F, Rodriguez LE, Suarez J & Curtidor Hea. Two MSA 2 peptides that bind to human red blood cells are relevant to Plasmodium falciparum merozoite invasion. J Pept Res 2000; 55: 216-223.
2. Stanley HA, Howard RF & Reese RT. Recognition of a Mr 56K glycoprotein on the surface of Plasmodium falciparum merozoites by mouse monoclonal antibodies. J Immunol 1985; 134: 3439-3444.
3. Fenton B, Clark JT, Wilson CF, McBride JS & Walliker D. Polymorphism of a 35-48kDa Plasmodium falciparum merozoite surface antigen. Mol Biochem Parasitol 1989; 34: 79-86.
4. Thomas AW, Carr DA, Carter JM & JA L. Sequence comparison of allelic forms of the Plasmodium falciparum merozoite surface antigen MSA2. Mol Biochem Parasitol 1990; 43: 211-220.
5. Taylor RR, Smith DB, Robinson VJ, McBride JS & Riley EM. Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass. Infect Immun 1995; 63: 4382-4388.
6. Anders RF. Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria. Parasite Immunol 1986; 8: 529-539.
7. Al-Yaman F, Genton B, Anders RF, et al. Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea. Am J Trop Med Hyg 1994; 51: 593-602.
8. Lyon JA, Thomas AW, Hall T & JD C. Specificities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytes. Mol Biochem Parasitol 1989; 36: 77-85.
9. Trager W & Jensen JBJ. Human malaria parasites in continuous culture. Science 1976; 193: 673-675.
10. Kramer KJ, Kan SC & Siddiqui WA. Concentration of Plasmodium falciparum-infected erythrocytes by density gradient centrifugation in Percoll. J Parasitol 1982; 68: 336-337.
11. Lambros C & Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 1979; 65: 418-420.
12. Smythe JA, Peterson MG, Coppel RL, Saul AJ, Kemp DJ & Anders RF. Structural diversity in the 45-kDa merozoite surface antigen of Plasmodium falciparum. Mol Biochem Parasitol 1990; 39: 227-234.
13. Rychlik W & Rhoads RE. A computer program for choosing optimal oligonucleotides for filter hybridization, sequencing and in vitro amplification of DNA. Nucleic Acids Res 1989; 17: 8543-8551.
14. Gilliland G, Perrin S, Blanchard K & Bunn HF. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci 1990; 87: 2725-2729.
15. Invitrogen. Library Efficiency DH5a Competent Cells. In: life technologies Il, Invitrogen Corporation USA. 2003-2006.
16. Amersham. GST Gene Fusion System Handbook. Edition AA, Amersham biosciences, Code No. 18-1157-58.
17. ® Plasmid Purification Handbook, 2nd edn. New York, 2003.
18. Strategen. BL21[DE3] PLysS competent cells. In Instruction Manual. 2004.
19. Al-Yaman F, Genton B, Anders R, et al. Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria. Parasite Immunol 1995; 17(9): 493-501.
20. Cornet M, Le Hesran JY, Fievet N, et al. Prevalence of and risk factors for anemia in young children in southern Cameroon. Am J Trop Med Hyg 1998; 58: 606-611.
21. Massawe SN, Ronquist G, Nystrom L & Lindmark G. Iron status and iron deficiency anaemia in adolescents in a Tanzanian suburban area. Gynecol Obstet Invest 2002; 54: 137-144.
22. Voller A, Bidwell D, Huldt G & Engvall E. A microplate method of enzyme-linked immunosorbent assay and its application to malaria. Bull World Health Organ 1974; 51: 209-211.
23. Lemma WF. Age Specific Anti-Plasmodium falciparum Immunity: A Study Based on the Keneba Data Collection. Liverpool, University of Liverpool, 1999.
24. Stowers A, Taylor D, Prescott N, Cheng Q, Cooper J & Saul A. Assessment of the humoral immune response against Plasmodium falciparum rhoptry-associated proteins 1 and 2. Infect Immun 1997; 65: 2329-2338.
25. Irion A. Molecular Diversity and Immunological Properties of the P. falciparum Merozoite Surface Protein-2[MSP-2]. Basel, University of Basel, 2000.
26. Irion A, Beck H & Smith T. Assessment of positivity in immuno-assays with variability in background measurements: a new approach applied to the antibody response to Plasmodium falciparum MSP2. J Immunol Methods 2002; 259: 111-118.
27. Ekala MT, Jouin H, Lekoulou F, Mercereau-Puijalon O & Ntoumi F. Allelic family-specific humoral responses to merozoite surface protein 2 (MSP2) in Gabonese residents with Plasmodium falciparum infections. Clin Exp Immunol 2002; 129(2): 326-331.
28. Wickramasinghe S & Abdalla S. Blood and bone marrow changes in malaria. Baillieres Best Pract Res Clin Haematol 2000; 13: 277-299.
29. Mockenhaupt F, Ehrhardt S, Eggelte T, Markert M, Anemana S & Otchwemah R. Plasmodium falciparum multiplicity correlates with anaemia in symptomatic malaria. Trop Med Int Health 2003; 8: 857-859.
30. Ndungu F, Bull P, Ross A, Lowe B, Kabiru E & Marsh K. Naturally acquired immunoglobulin [Ig] G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. Parasite Immunol 2002; 24: 77-82.
31. Kitua AY, Smith T, Alonso PL, et al. Plasmodium falciparum malaria in the first year of life in an area of intense and perennial transmission. Trop Med Int Health 1996; 1(4): 475-484.
32. Conway DJ, Greenwood BM & McBride JS. Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population. Infect Immun 1992; 60(3): 1122-1127.
33. Saul A, Cooper J, Hauquitz D, et al. The 42-kilodalton rhoptry-associated protein of Plasmodium falciparum. Mol Biochem Parasitol 1992; 50(1): 139-149.
34. Lougovskoi AA, Okoyeh NJ & Chauhan VS. Mice immunised with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain. Vaccine 1999; 18(9-10): 920-930.
35. Nagendran K & Ramasamy R. Isotypes of naturally acquired antibodies to a repetitive & non-repetitive epitope on Plasmodium falciparum surface proteins in an endemic area of Sri Lanka. Indian J Med Res 1996; 103: 142-145.
36. Taylor-Robinson AW. Immunoregulation of malarial infection: balancing the vices and virtues. Int J Parasitol 1998; 28(1): 135-148.
37. Metzger WG, Okenu DM, Cavanagh DR, et al. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria. Parasite Immunol 2003; 25(6): 307-312.
38. Cohen S, McGregor IA & Carrington SP. Gammaglobulin and acquired immunity to human malaria. Nature 1961; 192: 733-737.
39. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T & Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 1990; 172(6): 1633-1641.
40. Groux H & Gysin J. Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. Res Immunol 1990; 141(6): 529-542.
41. Aucan C, Traore Y, Tall F, et al. High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria. Infect Immun 2000; 68(3): 1252-1258.